VARIABLE GENE USE AND PNEUMOCOCCAL IMMUNITY IN AIDS

Medicine & Life Sciences

1. Streptococcus pneumoniae 100%
2. Antibodies 66%
3. HIV 60%
4. HIV Infections 48%
5. Epitopes 46%
6. Vaccines 40%
7. Pneumococcal Vaccines 40%
8. Acquired Immunodeficiency Syndrome 36%
9. Serogroup 29%
10. Pneumococcal Infections 26%
11. Antibody Specificity 26%
12. Genes 26%
13. Polysaccharides 20%
14. Antibody Formation 19%
15. Vaccination 17%
16. Research Personnel 15%
17. Cryptococcus 15%
18. Anti-Bacterial Agents 14%
19. AIDS Vaccines 14%
20. Peptides 13%
21. Immunoglobulin Genes 13%
22. Molecular Structure 13%
23. Manuscripts 12%
24. Consultants 11%
25. Immunocompromised Host 11%
26. Microbiology 11%
27. Penicillins 10%
28. Infections 10%
29. Transgenic Mice 9%
30. Immunoglobulins 9%
31. Publications 9%
32. Immunity 8%
33. Healthy Volunteers 7%
34. Gene Expression 6%
35. Morbidity 6%
36. Mortality 5%